Northwestern Mutual Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.3M | Buy |
127,910
+11,791
| +10% | +$1.47M | 0.01% | 482 |
|
|
2025
Q4 | $14.2M | Sell |
116,119
-4,085
| -3% | -$468K | 0.01% | 484 |
|
|
2025
Q3 | $12M | Buy |
120,204
+1,926
| +2% | +$173K | 0.01% | 507 |
|
|
2025
Q2 | $9.81M | Sell |
118,278
-15,248
| -11% | -$1.22M | 0.01% | 511 |
|
|
2025
Q1 | $10.8M | Sell |
133,526
-565,801
| -81% | -$50.6M | 0.01% | 464 |
|
|
2024
Q4 | $63M | Sell |
699,327
-391,610
| -36% | -$37.9M | 0.05% | 170 |
|
|
2024
Q3 | $108M | Sell |
1,090,937
-54,112
| -5% | -$5.32M | 0.1% | 100 |
|
|
2024
Q2 | $106M | Buy |
1,145,049
+18,202
| +2% | +$1.63M | 0.1% | 94 |
|
|
2024
Q1 | $107M | Sell |
1,126,847
-253,394
| -18% | -$23.5M | 0.11% | 92 |
|
|
2023
Q4 | $123M | Buy |
1,380,241
+1,357,188
| +5,887% | +$101M | 0.14% | 74 |
|
|
2023
Q3 | $1.68M | Sell |
23,053
-208,523
| -90% | -$16.7M | ﹤0.01% | 773 |
|
|
2023
Q2 | $19.3M | Buy |
231,576
+177,632
| +329% | +$14.9M | 0.02% | 277 |
|
|
2023
Q1 | $4.11M | Sell |
53,944
-39,210
| -42% | -$3.25M | 0.01% | 519 |
|
|
2022
Q4 | $7.73M | Buy |
93,154
+62,822
| +207% | +$5.09M | 0.01% | 377 |
|
|
2022
Q3 | $2.4M | Buy |
30,332
+4,055
| +15% | +$342K | ﹤0.01% | 577 |
|
|
2022
Q2 | $1.95M | Sell |
26,277
-698,126
| -96% | -$52.4M | ﹤0.01% | 631 |
|
|
2022
Q1 | $65.1M | Buy |
724,403
+688,740
| +1,931% | +$63.6M | 0.1% | 98 |
|
|
2021
Q4 | $3.99M | Buy |
35,663
+7,740
| +28% | +$934K | 0.01% | 459 |
|
|
2021
Q3 | $3.51M | Sell |
27,923
-1,416
| -5% | -$182K | 0.01% | 448 |
|
|
2021
Q2 | $3.97M | Sell |
29,339
-22,212
| -43% | -$2.92M | 0.01% | 414 |
|
|
2021
Q1 | $6.99M | Sell |
51,551
-17,295
| -25% | -$2.59M | 0.01% | 283 |
|
|
2020
Q4 | $9.69M | Sell |
68,846
-10,853
| -14% | -$1.39M | 0.02% | 234 |
|
|
2020
Q3 | $8.88M | Buy |
79,699
+3,805
| +5% | +$427K | 0.02% | 229 |
|
|
2020
Q2 | $8.5M | Buy |
75,894
+21,531
| +40% | +$2.12M | 0.03% | 215 |
|
|
2020
Q1 | $4.21M | Sell |
54,363
-20,264
| -27% | -$1.79M | 0.02% | 271 |
|
|
2019
Q4 | $7.1M | Sell |
74,627
-59,933
| -45% | -$5.18M | 0.02% | 231 |
|
|
2019
Q3 | $10.3M | Buy |
134,560
+2,757
| +2% | +$229K | 0.04% | 182 |
|
|
2019
Q2 | $11.6M | Buy |
131,803
+4,492
| +4% | +$383K | 0.05% | 160 |
|
|
2019
Q1 | $11.5M | Buy |
127,311
+6,205
| +5% | +$528K | 0.05% | 164 |
|
|
2018
Q4 | $8.69M | Sell |
121,106
-4,920
| -4% | -$396K | 0.04% | 181 |
|
|
2018
Q3 | $12.1M | Buy |
126,026
+5,635
| +5% | +$546K | 0.06% | 152 |
|
|
2018
Q2 | $11.5M | Buy |
120,391
+4,596
| +4% | +$422K | 0.06% | 147 |
|
|
2018
Q1 | $10.2M | Buy |
115,795
+15,837
| +16% | +$1.45M | 0.06% | 159 |
|
|
2017
Q4 | $8.48M | Buy |
99,958
+15,009
| +18% | +$1.26M | 0.05% | 165 |
|
|
2017
Q3 | $7.35M | Buy |
84,949
+5,235
| +7% | +$420K | 0.05% | 167 |
|
|
2017
Q2 | $6.15M | Buy |
79,714
+19,278
| +32% | +$1.37M | 0.05% | 172 |
|
|
2017
Q1 | $4.19M | Buy |
60,436
+4,918
| +9% | +$330K | 0.04% | 193 |
|
|
2016
Q4 | $3.29M | Buy |
+55,518
| New | +$3.43M | 0.04% | 214 |
|
|
2016
Q3 | – | Sell |
-1,295
| Closed | -$70K | – | 1558 |
|
|
2016
Q2 | $70K | Buy |
1,295
+503
| +64% | +$27.6K | ﹤0.01% | 827 |
|
|
2016
Q1 | $41K | Buy |
792
+495
| +167% | +$25.7K | ﹤0.01% | 963 |
|
|
2015
Q4 | $21K | Hold |
297
| – | – | ﹤0.01% | 994 |
|
|
2015
Q3 | $18K | Hold |
297
| – | – | ﹤0.01% | 950 |
|
|
2015
Q2 | $25K | Buy |
+297
| New | +$23.1K | ﹤0.01% | 826 |
|
Other funds holding XBI
Northwestern Mutual Wealth Management's XBI Position: Q1 2026 in Review
Northwestern Mutual Wealth Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 10% in Q1 2026, buying an estimated $1.47M and bringing the position to 127,910 shares worth $16.3M. The position accounts for 0.01% of the portfolio, ranked #482.
Northwestern Mutual Wealth Management first reported a position in XBI in Q2 2015 and has held it in 43 quarters since. The position peaked at $123M in Q4 2023. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Northwestern Mutual Wealth Management held 127,910 shares of State Street SPDR S&P Biotech ETF worth $16.3M as of Q1 2026.
- Northwestern Mutual Wealth Management bought 11,791 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $1.47M.
- State Street SPDR S&P Biotech ETF made up 0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #482 holding.
- Northwestern Mutual Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2015 and has held it in 43 quarters since.
- Northwestern Mutual Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $123M in Q4 2023.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.